LifeArc-Pharmaceuticals & Healthcare-Deals and Alliances Profile

LifeArc-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH193552D
  • |
  • Pages: 46
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

LifeArc, formerly Medical Research Council Technology, is a medical research charity that improves positive patient outcomes. The charity's activities include investing in promising projects, identifying and evaluating research, protecting assets with potential, and partnering with industry. It bridges the gap between basic research and commercial application and caters to the technology transfer. LifeArc's services include technology transfer and scientific development; developing abandoned and parked projects; antibody engineering; RNA and DNA protein based diagnostics; drug discovery, collaborative diagnostic assay development and validation; and licensing and partnering opportunities. It also focuses on RNA and DNA based diagnostics including oncology, infectious diseases, and precision medicine. The charity operates through various universities, medical research institutes, and pharmaceutical and biotechnology organizations. LifeArc is headquartered in London, the UK.

LifeArc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

LifeArc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

LifeArc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

LifeArc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

LifeArc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

LifeArc, Medical Devices Deals, 2011 to YTD 2017 10

LifeArc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

LifeArc, Pharmaceuticals & Healthcare, Deal Details 13

Partnerships 13

Metrion Biosciences Enters into Agreement with LifeArc 13

MRC Technology, UCB and University of Leicester Enter into Agreement 14

MRC Technology Enters into Co-Development Agreement with IPS-CAS 15

MRC Technology Partners with University of Lausanne 16

MRC Technology Enters into Agreement with Peptinnovate 17

MRC Technology Enters into Co-Development Agreement with NYU School of Medicine 18

MRC Technology Enters into Co-Development Agreement with Proximagen 19

AstraZeneca Extends Collaboration with MRC Technology 20

AstraZeneca Extends its Co-Development Agreement with MRC 21

MRC Technology Enters into Drug Discovery Agreement with Daiichi Sankyo 22

MRC Technology Enters Into Co-Development Agreement With Oxford University 23

MRC Technology Enters Into Co-Development Agreement With Boston University 24

MRC Technology Enters Into Agreement With EMBL Enterprise Management For Drug Development 25

MRC Technology Enters Into Co-Development Agreement With Institute of Biophysics Chinese Academy of Sciences 26

MRC Technology Enters Into Drug Discovery Agreement With Chinese Academy of Sciences 27

MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University 28

MRC Technology Enters Into Second Research Agreement With University of Bristol 29

Mount Sinai School of Medicine Enters Into Co-Development Agreement With MRC Technology 30

MRC Technology Enters Into Agreement With University of Bristol To Develop TrkA Antagonists 31

MRC Technology Enters Into Co-Development Agreement With University Of Aberdeen 32

Licensing Agreements 33

Shanghai Newsummit Biopharma Enters into Licensing Agreement with MRC Technology 33

Georg-August-University Gottingen Enters into Licensing Agreement with MRC Technology 34

MBM ScienceBridge, Georg-August-University Gottingen, University Medical Center Gottingen and MRC Technology, Enter into Licensing Agreement 35

Yabao Pharma Enters into Licensing Agreement with MRC Technology 36

Bio-Techne Enters into Licensing Agreement with MRC for Protein Synthesis Technology 37

UCB Enters Into Licensing Agreement With Medical Research Council Technology For Fibrosis Program 38

Asset Transactions 39

Pfizer Acquires Melanocortin Receptors from MRC Technology 39

LifeArc-Key Competitors 40

LifeArc-Key Employees 41

LifeArc-Locations And Subsidiaries 42

Head Office 42

Other Locations & Subsidiaries 42

Recent Developments 43

Government and Public Interest 43

Mar 01, 2016: US team tackle immune system in GBP875,000 Dementia Consortium project 43

Product News 44

Oct 20, 2016: KIDS CANCER-ACT NOW launched to accelerate treatments for children with cancer 44

Jun 27, 2017: LifeArc, Dstl and CDRD Collaborate to Identify Antibacterial Drug Targets 45

Appendix 46

Methodology 46

About GlobalData 46

Contact Us 46

Disclaimer 46

List of Figures

LifeArc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2

LifeArc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2

LifeArc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2

LifeArc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2

LifeArc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

LifeArc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

LifeArc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

LifeArc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

LifeArc, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

LifeArc, Pharmaceuticals & Healthcare, Key Facts 2

LifeArc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

LifeArc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

LifeArc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

LifeArc, Deals By Therapy Area, 2011 to YTD 2017 9

LifeArc, Medical Devices Deals, 2011 to YTD 2017 10

LifeArc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

Metrion Biosciences Enters into Agreement with LifeArc 13

MRC Technology, UCB and University of Leicester Enter into Agreement 14

MRC Technology Enters into Co-Development Agreement with IPS-CAS 15

MRC Technology Partners with University of Lausanne 16

MRC Technology Enters into Agreement with Peptinnovate 17

MRC Technology Enters into Co-Development Agreement with NYU School of Medicine 18

MRC Technology Enters into Co-Development Agreement with Proximagen 19

AstraZeneca Extends Collaboration with MRC Technology 20

AstraZeneca Extends its Co-Development Agreement with MRC 21

MRC Technology Enters into Drug Discovery Agreement with Daiichi Sankyo 22

MRC Technology Enters Into Co-Development Agreement With Oxford University 23

MRC Technology Enters Into Co-Development Agreement With Boston University 24

MRC Technology Enters Into Agreement With EMBL Enterprise Management For Drug Development 25

MRC Technology Enters Into Co-Development Agreement With Institute of Biophysics Chinese Academy of Sciences 26

MRC Technology Enters Into Drug Discovery Agreement With Chinese Academy of Sciences 27

MRC Technology Enters Into Drug Discovery Agreement With Queen Mary University 28

MRC Technology Enters Into Second Research Agreement With University of Bristol 29

Mount Sinai School of Medicine Enters Into Co-Development Agreement With MRC Technology 30

MRC Technology Enters Into Agreement With University of Bristol To Develop TrkA Antagonists 31

MRC Technology Enters Into Co-Development Agreement With University Of Aberdeen 32

Shanghai Newsummit Biopharma Enters into Licensing Agreement with MRC Technology 33

Georg-August-University Gottingen Enters into Licensing Agreement with MRC Technology 34

MBM ScienceBridge, Georg-August-University Gottingen, University Medical Center Gottingen and MRC Technology, Enter into Licensing Agreement 35

Yabao Pharma Enters into Licensing Agreement with MRC Technology 36

Bio-Techne Enters into Licensing Agreement with MRC for Protein Synthesis Technology 37

UCB Enters Into Licensing Agreement With Medical Research Council Technology For Fibrosis Program 38

Pfizer Acquires Melanocortin Receptors from MRC Technology 39

LifeArc, Key Competitors 40

LifeArc, Key Employees 41

LifeArc, Other Locations 42

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

LifeArc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license

Single User License
USD 250 INR 16120
Site License
USD 500 INR 32240
Corporate User License
USD 750 INR 48360

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com